Noumi (NOU) Q1 2027 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 TU earnings summary
23 Oct, 2026Executive summary
Q1 FY27 revenue was $160.2m, down 1.4% YoY; plant-based growth was offset by lower Dairy and Nutritionals sales. Trading was broadly consistent with management expectations.
Operating cash inflow was $7.9m, and quarter-end unrestricted cash was $15.3m; cash plus undrawn facilities totaled $25.3m.
Arrovest proposes to acquire shares and listed options it does not already own through schemes; meetings are scheduled for 5 November 2026.
Financial highlights
Consolidated Q1 FY27 revenue was $160.2m, down $2.3m or 1.4% YoY.
Operating cash inflow was $7.9m, including $2.0m of legacy-related legal and other payments; $1.6m of term-deposit release proceeds partly offset these payments.
Cash and cash equivalents increased $0.04m QoQ to $15.349m; operating inflow was largely offset by $5.810m net financing outflow and $2.034m net investing outflow.
Outlook and guidance
Q1 FY27 trading was broadly consistent with management expectations; financial guidance will not be provided.
The outlook remains cautious amid an unsettled macro environment, commodity-price movements, input-cost volatility, currency shifts, changing consumer demand and intense competition.
Latest events from Noumi
- Revenue and EBITDA rose, but major refinancing risk persists with 2027 note maturity.NOU
H2 2026 - EBITDA up 23.3% to $33.9m, but $610.4m convertible notes maturity poses major risk.NOU
H1 2026 - Q1 FY26 revenue rose 9% to $162.4M, with strong cash flow and improved liquidity.NOU
Q1 2026 TU - Record growth in plant-based milks and strategic expansion drive robust FY25 results.NOU
AGM 2025 Presentation - EBITDA up 13% to $57.4m, revenue up, legacy issues resolved, and 2027 note maturity planning.NOU
H2 2025 - Revenue up 2.6% to $149.1M, strong plant-based growth, solid cash flow, dairy exports weak.NOU
Q1 2025 - Record revenue and EBITDA growth led by Plant-based Milks, but net loss widened on non-cash charges.NOU
H2 2024 - EBITDA up 19% to $27.5M, but net loss widened to $82.1M on non-cash charges.NOU
H1 2025